We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBH icon
1576
Sally Beauty Holdings
SBH
$1.51B
$3.59M ﹤0.01%
334,459
+14,046
+4% +$154K
CDE icon
1577
Coeur Mining
CDE
$16.1B
$3.59M ﹤0.01%
638,343
+96,536
+18% +$498K
DHT icon
1578
DHT Holdings
DHT
$2.96B
$3.58M ﹤0.01%
309,826
-9,105
-3% -$107K
WS icon
1579
Worthington Steel
WS
$1.89B
$3.58M ﹤0.01%
107,273
+1,047
+1% +$34.3K
CLDX icon
1580
Celldex Therapeutics
CLDX
$3.26B
$3.57M ﹤0.01%
96,480
-2,050
-2% -$77.3K
FRSH icon
1581
Freshworks
FRSH
$3.2B
$3.57M ﹤0.01%
281,379
+54,293
+24% +$812K
KW
1582
DELISTED
Kennedy-Wilson Holdings
KW
$3.56M ﹤0.01%
366,681
-14,109
-4% -$132K
PTCT icon
1583
PTC Therapeutics
PTCT
$5.91B
$3.56M ﹤0.01%
116,396
+7,314
+7% +$237K
PENG
1584
Penguin Solutions Inc
PENG
$2.88B
$3.54M ﹤0.01%
154,867
+2,854
+2% +$59.4K
NUVL
1585
DELISTED
Nuvalent
NUVL
$3.54M ﹤0.01%
46,611
+7,420
+19% +$528K
CSGS
1586
DELISTED
CSG Systems International
CSGS
$3.51M ﹤0.01%
85,329
-1,011
-1% -$44.8K
BROS icon
1587
Dutch Bros
BROS
$9.32B
$3.51M ﹤0.01%
84,776
+83,521
+6,655% +$2.87M
MIR icon
1588
Mirion Technologies
MIR
$3.74B
$3.5M ﹤0.01%
325,569
+1,340
+0.4% +$14.2K
DVAX
1589
DELISTED
Dynavax Technologies
DVAX
$3.49M ﹤0.01%
310,805
+5,379
+2% +$62.6K
KB icon
1590
KB Financial Group
KB
$42.6B
$3.48M ﹤0.01%
61,558
-38,184
-38% -$2.08M
CSR
1591
Centerspace
CSR
$940M
$3.48M ﹤0.01%
51,492
-306
-0.6% -$20.2K
SAFT icon
1592
Safety Insurance
SAFT
$1.52B
$3.48M ﹤0.01%
46,398
-785
-2% -$61.6K
UEC icon
1593
Uranium Energy
UEC
$5.32B
$3.47M ﹤0.01%
578,061
-56,192
-9% -$382K
ADMA icon
1594
ADMA Biologics
ADMA
$2.25B
$3.47M ﹤0.01%
310,539
+15,844
+5% +$133K
STEL
1595
DELISTED
Stellar Bancorp
STEL
$3.47M ﹤0.01%
151,034
+1,833
+1% +$41.6K
ARLO icon
1596
Arlo Technologies
ARLO
$1.68B
$3.46M ﹤0.01%
265,669
+8,389
+3% +$104K
AGR
1597
DELISTED
Avangrid, Inc.
AGR
$3.46M ﹤0.01%
97,417
+5,971
+7% +$215K
COLL icon
1598
Collegium Pharmaceutical
COLL
$944M
$3.46M ﹤0.01%
107,364
+2,966
+3% +$103K
CWAN
1599
DELISTED
Clearwater Analytics
CWAN
$3.44M ﹤0.01%
185,948
+183,700
+8,172% +$3.31M
EVH icon
1600
Evolent Health
EVH
$404M
$3.44M ﹤0.01%
180,059
+13,867
+8% +$354K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.